Hepatitis Rapid Testing Market – Europe Market Expected to Record a Relatively High Value CAGR Through 2030

Healthcare
According to latest research by Fact MR, hepatitis rapid testing market will experience substantial growth with CAGR of XX% during the forecast period 2021-2031. Increased demand for hepatitis rapid testing due to the high prevalence of hepatitis infections and increasing awareness about treatment and procedures available can give boost to this market.

Request Brochure

Key Segments

  • By Product Type

    • Test Strip
    • Cassette
  • By Test Type

    • Rapid Diagnostic Tests/ Point-of-care Tests
    • Immunoassay Tests
      • ELISA Kits
      • Enzyme Immunoassay kit
    • Molecular assay Tests
      • Nucleic Acid Test/ PCR test
  • By Usage

    • Clinical Diagnostics
    • Academic Research Centers
  • By End Users

    • Diagnostic Centers
    • Pathology Laboratories
    • Research Centers
    • Specialty Clinics
    • Hospitals
  • By Region

    • North America
    • Latin America
    • Europe
    • South Asia
    • East Asia
    • Oceania
    • Middle East and Africa

Who are the Key Manufacturers and Suppliers of Hepatitis Rapid Testing?

Some of the leading manufacturers operating in the Hepatitis Rapid Testing include

  • Abbott
  • Standard Diagnostics Inc
  • DiaSorin S.p.A
  • SD Biosensor
  • Kehua-Bio-Engineering Co. Ltd.
  • bioMerieux SA
  • Biokit S.A.
  • RPC Diagnostics System
  • Dia Pro- Diagnostic Bioprobes s.r.l.
  • Creative Diagnostics
  • Asan Pharm Co. Ltd.
  • Fujirebio
  • Orasure Technologies
  • InTec Products Inc.
  • Bio-Rad Laboratories Inc
  • Sysmex Asia Pacific Pte Ltd.
  • F. Hoffmann- La Roche Ltd.

 

Leave a Reply

Related Posts